Search International and National Patent Collections

5. (WO2011121351) USE OF THE PHYTOCANNABINOID CANNABIDIVARIN (CBDV) IN THE TREATMENT OF EPILEPSY

Pub. No.:    WO/2011/121351    International Application No.:    PCT/GB2011/050649
Publication Date: Fri Oct 07 01:59:59 CEST 2011 International Filing Date: Thu Mar 31 01:59:59 CEST 2011
IPC: A61K 31/05
A61K 31/19
A61K 31/352
A61K 31/40
A61K 36/185
A61K 45/06
A61P 25/08
Applicants: GW PHARMA LIMITED
OTSUKA PHARMACEUTICAL CO., LIMITED
WHALLEY, Benjamin
WILLIAMS, Claire
STEPHENS, Gary
FUTAMURA, Takashi
Inventors: WHALLEY, Benjamin
WILLIAMS, Claire
STEPHENS, Gary
FUTAMURA, Takashi
Title: USE OF THE PHYTOCANNABINOID CANNABIDIVARIN (CBDV) IN THE TREATMENT OF EPILEPSY
Abstract:
This invention relates to the use of the phytocannabinoid cannabidivarin (CBDV) and combinations of the phytocannabinoid CBDV with tetrahydrocannabivarin (THCV) and cannabidiol (CBD) in the treatment of epilepsy. The invention further relates to the use of the phytocannabinoid CBDV in combination with standard anti-epileptic drugs (SAEDs). Preferably the SAED is one of ethosuximide, valproate or phenobarbital.